Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Audentes Therapeutics Inc. (BOLD)

36.08   1.79 (5.22%) 07-15 16:00
Open: 34.4 Pre. Close: 34.29
High: 36.19 Low: 34.15
Volume: 309,371 Market Cap: 1598M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 36.242 - 36.445 36.445 - 36.63
Low: 33.63 - 33.888 33.888 - 34.124
Close: 35.691 - 36.08 36.08 - 36.436

Technical analysis

as of: 2019-07-15 4:40:39 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 44.81     One year: 48.18
Support: Support1: 33.69    Support2: 28.03
Resistance: Resistance1: 38.36    Resistance2: 41.25
Pivot: 36.68
Moving Average: MA(5): 35.15     MA(20): 37.55
MA(100): 37.13     MA(250): 32.47
MACD: MACD(12,26): -0.78     Signal(9): -0.46
Stochastic oscillator: %K(14,3): 15.36     %D(3): 9.95
RSI: RSI(14): 45.52
52-week: High: 42.69  Low: 17.95  Change(%): -4.3
Average Vol(K): 3-Month: 58487  10-Days: 39600

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BOLD has closed above bottom band by 39.1%. Bollinger Bands are 13.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 24 May 2019 20:57:15 Z
After Hours Most Active for May 24, 2019 : TRUE, ING, F, FCAU, INFY, CNHI, QQQ, AES, CROX, XOG, BOLD, MOBL

Wed, 08 May 2019 15:51:49 Z
Audentes Therapeutics, Inc. (BOLD) Q1 2019 Earnings Call Transcript

Thu, 07 Mar 2019 16:18:26 Z
Audentes Therapeutics (BOLD) Upgraded to Buy: Here's What You Should Know

Thu, 28 Feb 2019 20:07:21 Z
BOLD Makes Bullish Cross Above Critical Moving Average

Thu, 28 Feb 2019 04:08:06 Z
Audentes Therapeutics, Inc. (BOLD) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 21.73
Shares Float (M) 40.86
% Held by Insiders 7.46
% Held by Institutions 103.43
Shares Short (K) 1790
Shares Short P. Month (K)

Stock Financials

EPS -3.810
EPS Est. Current Year -3.500
EPS Est. Next Year -3.630
EPS Est. Next Quarter -0.900
Forward EPS -3.461
Book Value (p.s.) 9.190
PEG Ratio -0.60
Profit Margin
Operating Margin
Return on Assets (ttm) -24.1
Return on Equity (ttm) -40.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -7.069
Qtrly Earnings Growth
Operating Cash Flow (M) -125.61
Levered Free Cash Flow (M) -79.65

Stock Valuations

P/E -9.47
P/E Growth Ratio 0.05
P/BV 3.93
P/CF -6.24

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.